Fibrocell Science Inc (FCSC)

[biolover]

Currently, our physician training and educational materials are with the U.S. Food and Drug Administration (FDA) for review. Following FDA feedback, physician training will begin in September. We expect to be able to share more information with you in late August about this promising new treatment and the launch of our new Web site. Thank you and continue to stay tuned for ongoing updates.

The LAVIV® Team

i think this is the answer to your question Rickkk. they can not legally do what you are asking if laviv is still under review by FDA!